Table 1.
Socio-demographic and clinical data of patients included in the study.
| Variable | Children (6–11) | Adolescents (12–17) | Adults (≥18) | Total | p-value | |
|---|---|---|---|---|---|---|
| Age | n | 116† | 87† | 388† | 591† | <0.0001 |
| Average (SD) | 9.0 (1.5) | 14.5 (1.8) | 33.9 (11.2) | 26.2 (14.2) | ||
| Gender | Male | 75 (64.7%) | 54 (62.1%) | 194 (50.0%) | 323 (54.7%) | 0.0067 |
| Habitat | Rural (<10,000 pop.) | 11 (9.5%) | 10 (11.5%) | 51 (13.2%) | 72 (12.2%) | 0.4199 |
| Semi-urban (>10,000–<30,000 pop.) | 11 (9.5%) | 7 (8.0%) | 50 (13.0%) | 68 (11.5%) | ||
| Urban (>30,000–<200,000 pop.) | 68 (58.6%) | 48 (55.2%) | 184 (47.7%) | 300 (50.9%) | ||
| Metropolitan (>200,000 pop.) | 26 (22.4%) | 22 (25.3%) | 101 (26.2%) | 149 (25.3%) | ||
| Level of education | No formal education | 6 (9.4%) | - | 4 (1.1%) | 10 (2.0%) | <0.0001 |
| Primary education | 57 (89.1%) | 20 (30.8%) | 52 (14.0%) | 129 (25.8%) | ||
| Secondary education | 1 (1.6%) | 43 (66.2%) | 139 (37.5%) | 183 (36.6%) | ||
| University education | 2 (3.1%) | 176 (47.4%) | 178 (35.6%) | |||
| Employment status | Unemployed | 23 (6.2%) | 23 (4.7%) | <0.0001 | ||
| Self-employed | 37 (10.0%) | 37 (7.5%) | ||||
| Employed by other | 210 (56.9%) | 210 (42.5%) | ||||
| Unable to work | 1 (0.3%) | 1 (0.2%) | ||||
| Pensioner | 10 (2.7%) | 10 (2.0%) | ||||
| Housework | 18 (4.9%) | 18 (3.6%) | ||||
| Student | 58 (100.0%) | 67 (100.0%) | 70 (19.0%) | 195 (39.5%) | ||
| Duration of ARC | Average (SD) years | 3.9 (2.0) | 5.9 (3.3) | 10.4 (8.7) | 8.45 (7.7) | <0.0001 |
| Diagnosis method | Skin prick-test | 115 (99.1%) | 87 (100.0%) | 385 (99.2%) | 587 (99.3%) | 0.7027 |
| Specific classic IgE | 71 (61.2%) | 45 (51.7%) | 181 (46.6%) | 297 (50.3%) | 0.0217 | |
| Molecular diagnosis | 27 (23.3%) | 25 (28.7%) | 89 (22.9%) | 141 (23.9%) | 0.5113 | |
| Other | 3 (2.6%) | 1 (1.1%) | 12 (3.1%) | 16 (2.7%) | 0.5984 | |
| Comorbidities | Yes | 94 (81.0%) | 66 (75.9%) | 263 (67.8%) | 423 (71.6%) | 0.0134 |
| Asthma | 72 (62.1%) | 54 (62.1%) | 206 (53.1%) | 332 (56.2%) | 0.1129 | |
| Sinusitis | 4 (3.4%) | 2 (2.3%) | 23 (5.9%) | 29 (4.9%) | 0.2640 | |
| Nasal polyposis | 1 (0.9%) | 2 (0.5%) | 3 (0.5%) | 0.6932 | ||
| Medium otitis | 5 (4.3%) | 1 (1.1%) | 6 (1.5%) | 12 (2.0%) | 0.1475 | |
| Eczema | 13 (11.2%) | 3 (3.4%) | 19 (4.9%) | 35 (5.9%) | 0.0235 | |
| Urticaria | 2 (1.7%) | 6 (6.9%) | 12 (3.1%) | 20 (3.4%) | 0.1130 | |
| Atopic dermatitis | 32 (27.6%) | 10 (11.5%) | 25 (6.4%) | 67 (11.3%) | <0.0001 | |
| Headache | 5 (4.3%) | 5 (5.7%) | 36 (9.3%) | 46 (7.8%) | 0.1604 | |
| Food allergy | 15 (12.9%) | 8 (9.2%) | 44 (11.3%) | 67 (11.3%) | 0.7081 | |
| Drugs allergy | 1 (1.1%) | 16 (4.1%) | 17 (2.9%) | 0.0383 | ||
| Other | 5 (4.3%) | 1 (1.1%) | 14 (3.6%) | 20 (3.4%) | 0.4290 |
†
Total evaluated unless specified otherwise.
SD=standard deviation.